Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells

被引:0
作者
Zhen-yu Shi
Yong-qiang Li
Yu-hua Kang
Guo-qiang Hu
Chao-shen Huang-Fu
Jin-bo Deng
Bin Liu
机构
[1] Institute of Neurobiology,
[2] College of Nursing,undefined
[3] He-nan University,undefined
[4] Huai-he Clinical College,undefined
[5] He-nan University,undefined
[6] Institute of Chemical Biology,undefined
[7] He-nan University,undefined
来源
Acta Pharmacologica Sinica | 2012年 / 33卷
关键词
anticancer drug; fluoroquinolone; piperonal ciprofloxacin hydrazone; hepatocarcinoma cells; breast adenocarcinoma cells; colon adenocarcinoma cells; apoptosis; topoisomerase II; mitochondrial membrane potential;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:271 / 278
页数:7
相关论文
共 154 条
[1]  
Bolon MK(2009)The newer fluoroquinolones Infect Dis Clin North Am 23 1027-51
[2]  
Bax BD(2010)Type IIA topoisomerase inhibition by a new class of antibacterial agents Nature 466 935-40
[3]  
Chan PF(2007)Functionalized N-(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents J Pharm Pharm Sci 10 153-8
[4]  
Eggleston DS(1992)Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity Cancer Res 52 2818-22
[5]  
Fosberry A(1999)Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer Urology 54 56-61
[6]  
Gentry DR(2010)Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells J Physiol Pharmacol 61 233-9
[7]  
Gorrec F(2010)Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II PLoS One 5 e10186-20
[8]  
Rajabalian S(2009)N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study Biomed Pharmacother 63 16-91
[9]  
Foroumadi A(2009)Design and synthesis of 2-(3-benzo[b]thienyl)-6,7-methylenedioxyquinolin-4-one analogues as potent antitumor agents that inhibit tubulin assembly J Med Chem 52 4883-61
[10]  
Shafiee A(2009)Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification J Med Chem 52 5649-5